Fayolle Martin, Souweine Jean-Sébastien, Mathieu Olivier, Bargnoux Anne-Sophie, Cristol Jean-Paul, Badiou Stéphanie
Laboratoire de biochimie, Hôpital Lapeyronie, CHU Montpellier, France.
Laboratoire de biochimie, Hôpital Lapeyronie, CHU Montpellier, France, Phymedexp, Université de Montpellier, Inserm, CNRS, CHU de Montpellier, Montpellier, France.
Ann Biol Clin (Paris). 2020 Aug 1;78(4):449-453. doi: 10.1684/abc.2020.1570.
Nephrogenic diabetes insipidus due to the inability of the kidneys to concentrate urine is frequently observed during lithium therapy. Lithium concentrates into principal cells in collecting ducts in the kidney and downregulates aquaporin 2 expression, which reduces renal reabsorption of water. This disease is characterized by polyuria - polydipsia leading to intracellular dehydration and hypernatremia. Water deprivation test is performed to confirm insipidus diabetes. The desmopressin permits to distinguish nephrogenic from cranial insipidus diabetes. We report the case of a 64 years old women who presented with global dehydration and severe hypernatremia. Four years ago, she was hospitalized for nephrogenic diabetes insipidus related to a self-induced lithium intoxication. Persistent nephrogenic insipidus diabetes after cessation of lithium therapy are described in literature, and this hypothesis may be consistent with this case report.
锂治疗期间经常会出现因肾脏无法浓缩尿液而导致的肾性尿崩症。锂会在肾脏集合管的主细胞中聚集,并下调水通道蛋白2的表达,从而减少肾脏对水的重吸收。这种疾病的特征是多尿-烦渴,导致细胞内脱水和高钠血症。进行禁水试验以确诊尿崩症。去氨加压素可用于区分肾性尿崩症和中枢性尿崩症。我们报告了一例64岁女性,她出现了全身性脱水和严重高钠血症。四年前,她因自行服用锂导致中毒而住院,被诊断为肾性尿崩症。文献中描述了锂治疗停止后持续性肾性尿崩症的情况,该假设可能与本病例报告相符。